R&D When biology becomes a language: Biodata teaching Dr Shai Melcer, head of bio-convergence at the Israel Innovation Authority, discusses biology as a language ahead of Biomed Israel 2026.
R&D On the ICH E20 draft guideline (2025) for adaptive clinical ... A review of the scope, key principles, methodological expectations, and regulatory implications of ICH E20.
R&D Sandoz on the future of generics and biosimilars in Europe At Reuters Pharma Europe, Sandoz' Claire D'Abreu-Hayling explored the promise of the so-called “golden decade” of patent expiry for generics.
R&D Longevity studies in life sciences today Longevity has been discussed for a while now in the context of life sciences and pharma - we take a look at what's new now with Anat Naschitz.
R&D Why everyone should care about longevity, with Boyang Wang In today’s episode of the pharmaphorum podcast, host Jonah Comstock speaks with Boyang Wang, the founder of Immortal Dragons.
R&D Beyond proof of concept: Alzheimer’s and the next chapter of... Research has demonstrated that some individuals at elevated risk of Alzheimer's disease can be identified before symptoms emerge.
Digital Trustworthy and novel AI in clinical trial planning, with Kr... Norstella's Kris Kaneta discusses why patient-level data is pharma's most important asset, as well as expanding the efficacy of AI for clinical trials
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
